SCHEMBL6428107

SCHEMBL6428107

COC(=O)c1cc(C=O)ccc1-c1ccco1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.50
PTPN2 P17706 2/20 0.46
PTPN1 P18031 2/20 0.46
PTPN6 P29350 2/20 0.46
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 5/20 0.45
NR4A2 P43354 1/20 0.44
AXL P30530 1/20 0.44
MAPT P10636 2/20 0.43
RECQL P46063 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
POLB P06746 3/20 0.43
RAB9A P51151 1/20 0.43
CACNA1B Q00975 1/20 0.43
APBA1 Q02410 1/20 0.43
HSP90AA1 P07900 2/20 0.42
HPGD P15428 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426460 0.83 PTPN1 (0.60) CFTRPTPN2PTPN1PTPN6ALDH1A1
SCHEMBL6959707 0.83 CFTR (0.49) CFTRPTPN1ALDH1A1KDM4ENR4A2
SCHEMBL2726214 0.81 CFTR (0.58) CFTRALDH1A1KDM4ENR4A2AXL
SCHEMBL6959703 0.80 CFTR (0.51) CFTRALDH1A1KDM4ENR4A2AXL
SCHEMBL28366655 0.78 KDM4E (0.56) CFTRALDH1A1KDM4ENR4A2AXL
SCHEMBL27284666 0.78 ERN1 (0.52) CFTRPTPN2PTPN1PTPN6ALDH1A1
SCHEMBL2568133 0.77 CYP1A2 (0.51) ALDH1A1KDM4EMAPTRECQLRAB9A
SCHEMBL4134287 0.76 KDM4E (0.54) CFTRALDH1A1KDM4ENR4A2AXL
SCHEMBL11469172 0.74 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTRAB9AHSP90AA1
SCHEMBL5033639 0.74 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTRAB9AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050042674-A9 Common ligand mimics: thiazolidinediones and rhodanines TRIAD THERAPEUTICS, INC. 2005-02-24 US disclosed
US-20040009526-A1 Common ligand mimics: thiazolidinediones and rhodanines YU LIN (US) 2004-01-15 US disclosed
WO-2003072033-A2 COMMON LIGAND MIMICS: THIAZOLIDINEDIONES AND RHODANINES TRIAD THERAPEUTICS, INC. (US) 2003-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009526-A1 Common ligand mimics: thiazolidinediones and rhodanines GPR65, NR2E3, FGFR3 CFTR 717/4885PTPN2 977/4885PTPN1 1174/4885
US-20050042674-A9 Common ligand mimics: thiazolidinediones and rhodanines GPR65, NR2E3, FGFR3 CFTR 717/4885PTPN2 977/4885PTPN1 1174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.